Prof. Liang Zhao 赵亮
Chief Physician, Professor
Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Early diagnosis and comprehensive treatment of liver, gallbladder, pancreas, and spleen diseases. Expertise includes standardized liver cancer therapy, precise hepatectomy, hemangioma resection, and pancreaticoduodenectomy for pancreatic, bile duct, and duodenal cancers.
Dr. Zhao has over ten years of clinical experience, performing nearly 200 hepatobiliary and pancreatic surgeries annually. The doctor has led three research projects and received multiple provincial medical technology awards. Dr. Zhao has published over 10 papers, including 4 in SCI-indexed journals.
Professional roles
- Chair, Youth Committee of Hepatobiliary and Pancreatic Tumor Branch, Heilongjiang Medical Association
- Secretary, Liver Cancer Professional Committee, Heilongjiang Anti-Cancer Association
- Standing Committee Member, Youth Committee of Soft Tissue Tumor Branch, China International Exchange and Promotion Association for Medical and Healthcare
- Member, Youth Committee of Liver Tumor Branch, China International Exchange and Promotion Association for Medical and Healthcare
Name order: in Chinese the family name comes first (Zhao Liang). Papers usually list the name as Liang Zhao or Zhao L.
Selected publications
8 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Aging (Albany NY), 2020 (senior author): LncRNA PVT1 promotes exosome secretion through YKT6, RAB7, and VAMP3 in pancreatic cancer. PubMed 32499447
- J Cell Physiol, 2018 (first author): Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis. PubMed 29319182
- Oncol Res, 2016 (senior author): Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest. PubMed 27098147
- Exp Ther Med, 2016 (first author): Palliation double stenting for malignant biliary and duodenal obstruction. PubMed 26889267
- Biochem Biophys Res Commun, 2015 (first author): miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. PubMed 25580008
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion